This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: CYP2C8 Activity Recovers within 96 Hours after Gemfibrozil Dosing: Estimation of CYP2C8 Half-Life Using Repaglinide as an in Vivo Probe, Drug Metabolism and Disposition, September 2009, American Society for Pharmacology & Experimental Therapeutics (ASPET),
DOI: 10.1124/dmd.109.029728.
You can read the full text:
The following have contributed to this page
